nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—ADK—epilepsy syndrome	0.676	1	CbGaD
Vidarabine—ADORA2A—ganglion—epilepsy syndrome	0.0038	0.137	CbGeAlD
Vidarabine—ADORA2A—forebrain—epilepsy syndrome	0.0016	0.0575	CbGeAlD
Vidarabine—ADORA2A—telencephalon—epilepsy syndrome	0.00147	0.0528	CbGeAlD
Vidarabine—ADK—forebrain—epilepsy syndrome	0.00143	0.0516	CbGeAlD
Vidarabine—ADK—telencephalon—epilepsy syndrome	0.00132	0.0475	CbGeAlD
Vidarabine—ADK—medulla oblongata—epilepsy syndrome	0.00104	0.0373	CbGeAlD
Vidarabine—ADORA2A—spinal cord—epilepsy syndrome	0.00103	0.037	CbGeAlD
Vidarabine—ADA—head—epilepsy syndrome	0.001	0.0362	CbGeAlD
Vidarabine—ADA—nervous system—epilepsy syndrome	0.000952	0.0343	CbGeAlD
Vidarabine—ADK—midbrain—epilepsy syndrome	0.000946	0.0341	CbGeAlD
Vidarabine—ADK—spinal cord—epilepsy syndrome	0.000923	0.0332	CbGeAlD
Vidarabine—ADA—central nervous system—epilepsy syndrome	0.000917	0.033	CbGeAlD
Vidarabine—ADORA2A—head—epilepsy syndrome	0.000914	0.0329	CbGeAlD
Vidarabine—Adenosine triphosphate—AFG3L2—epilepsy syndrome	0.000885	0.161	CrCbGaD
Vidarabine—ADORA2A—nervous system—epilepsy syndrome	0.000866	0.0312	CbGeAlD
Vidarabine—Ribavirin—ADK—epilepsy syndrome	0.000852	0.155	CrCbGaD
Vidarabine—ADORA2A—central nervous system—epilepsy syndrome	0.000834	0.03	CbGeAlD
Vidarabine—ADK—head—epilepsy syndrome	0.000821	0.0296	CbGeAlD
Vidarabine—ADORA2A—cerebellum—epilepsy syndrome	0.000815	0.0294	CbGeAlD
Vidarabine—DPP4—head—epilepsy syndrome	0.000796	0.0286	CbGeAlD
Vidarabine—ADK—nervous system—epilepsy syndrome	0.000778	0.028	CbGeAlD
Vidarabine—DPP4—nervous system—epilepsy syndrome	0.000754	0.0272	CbGeAlD
Vidarabine—ADK—central nervous system—epilepsy syndrome	0.000749	0.027	CbGeAlD
Vidarabine—ADK—cerebellum—epilepsy syndrome	0.000732	0.0264	CbGeAlD
Vidarabine—ADA—brain—epilepsy syndrome	0.000728	0.0262	CbGeAlD
Vidarabine—DPP4—central nervous system—epilepsy syndrome	0.000726	0.0262	CbGeAlD
Vidarabine—Adenosine—ADK—epilepsy syndrome	0.00069	0.125	CrCbGaD
Vidarabine—ADORA2A—brain—epilepsy syndrome	0.000662	0.0238	CbGeAlD
Vidarabine—Cytarabine—NT5E—epilepsy syndrome	0.00065	0.118	CrCbGaD
Vidarabine—ADK—brain—epilepsy syndrome	0.000595	0.0214	CbGeAlD
Vidarabine—DPP4—brain—epilepsy syndrome	0.000577	0.0208	CbGeAlD
Vidarabine—Adenosine monophosphate—ADK—epilepsy syndrome	0.000499	0.0906	CrCbGaD
Vidarabine—Adenosine triphosphate—ADK—epilepsy syndrome	0.000432	0.0785	CrCbGaD
Vidarabine—Glucosamine—MMP9—epilepsy syndrome	0.000283	0.0514	CrCbGaD
Vidarabine—Glucosamine—TNF—epilepsy syndrome	0.000186	0.0338	CrCbGaD
Vidarabine—Adenosine triphosphate—AKT1—epilepsy syndrome	0.000182	0.0331	CrCbGaD
Vidarabine—Adenosine monophosphate—SRC—epilepsy syndrome	0.00018	0.0326	CrCbGaD
Vidarabine—Tenofovir—ABCC2—epilepsy syndrome	0.00016	0.0291	CrCbGaD
Vidarabine—Clofarabine—ABCG2—epilepsy syndrome	0.000157	0.0284	CrCbGaD
Vidarabine—Glucosamine—CYP2C19—epilepsy syndrome	0.000142	0.0258	CrCbGaD
Vidarabine—Hypersensitivity—Vigabatrin—epilepsy syndrome	9.88e-05	0.000501	CcSEcCtD
Vidarabine—Asthenia—Fosphenytoin—epilepsy syndrome	9.87e-05	0.0005	CcSEcCtD
Vidarabine—Dyspnoea—Lamotrigine—epilepsy syndrome	9.85e-05	0.000499	CcSEcCtD
Vidarabine—Angioedema—Valproic Acid—epilepsy syndrome	9.83e-05	0.000498	CcSEcCtD
Vidarabine—Somnolence—Lamotrigine—epilepsy syndrome	9.82e-05	0.000498	CcSEcCtD
Vidarabine—Pain—Carbamazepine—epilepsy syndrome	9.78e-05	0.000495	CcSEcCtD
Vidarabine—Dizziness—Propofol—epilepsy syndrome	9.76e-05	0.000495	CcSEcCtD
Vidarabine—Hypersensitivity—Diazepam—epilepsy syndrome	9.73e-05	0.000493	CcSEcCtD
Vidarabine—Asthenia—Vigabatrin—epilepsy syndrome	9.63e-05	0.000488	CcSEcCtD
Vidarabine—Urticaria—Clonazepam—epilepsy syndrome	9.58e-05	0.000485	CcSEcCtD
Vidarabine—Tinnitus—Gabapentin—epilepsy syndrome	9.55e-05	0.000484	CcSEcCtD
Vidarabine—Dizziness—Midazolam—epilepsy syndrome	9.55e-05	0.000484	CcSEcCtD
Vidarabine—Tension—Pregabalin—epilepsy syndrome	9.55e-05	0.000484	CcSEcCtD
Vidarabine—Dysgeusia—Pregabalin—epilepsy syndrome	9.53e-05	0.000483	CcSEcCtD
Vidarabine—Urticaria—Phenytoin—epilepsy syndrome	9.52e-05	0.000482	CcSEcCtD
Vidarabine—Cardiac disorder—Gabapentin—epilepsy syndrome	9.51e-05	0.000482	CcSEcCtD
Vidarabine—Palpitations—Valproic Acid—epilepsy syndrome	9.51e-05	0.000482	CcSEcCtD
Vidarabine—Asthenia—Diazepam—epilepsy syndrome	9.48e-05	0.00048	CcSEcCtD
Vidarabine—Urticaria—Oxcarbazepine—epilepsy syndrome	9.47e-05	0.00048	CcSEcCtD
Vidarabine—Pain—Lamotrigine—epilepsy syndrome	9.45e-05	0.000479	CcSEcCtD
Vidarabine—Nervousness—Pregabalin—epilepsy syndrome	9.45e-05	0.000479	CcSEcCtD
Vidarabine—Nausea—Acetazolamide—epilepsy syndrome	9.44e-05	0.000478	CcSEcCtD
Vidarabine—Dizziness—Levetiracetam—epilepsy syndrome	9.43e-05	0.000478	CcSEcCtD
Vidarabine—Back pain—Pregabalin—epilepsy syndrome	9.41e-05	0.000477	CcSEcCtD
Vidarabine—Cough—Valproic Acid—epilepsy syndrome	9.39e-05	0.000476	CcSEcCtD
Vidarabine—Vomiting—Propofol—epilepsy syndrome	9.38e-05	0.000476	CcSEcCtD
Vidarabine—Rash—Propofol—epilepsy syndrome	9.31e-05	0.000472	CcSEcCtD
Vidarabine—Dermatitis—Propofol—epilepsy syndrome	9.3e-05	0.000471	CcSEcCtD
Vidarabine—Hypertension—Valproic Acid—epilepsy syndrome	9.29e-05	0.000471	CcSEcCtD
Vidarabine—Headache—Propofol—epilepsy syndrome	9.25e-05	0.000469	CcSEcCtD
Vidarabine—Mediastinal disorder—Gabapentin—epilepsy syndrome	9.23e-05	0.000468	CcSEcCtD
Vidarabine—Hypersensitivity—Zonisamide—epilepsy syndrome	9.22e-05	0.000467	CcSEcCtD
Vidarabine—Vomiting—Midazolam—epilepsy syndrome	9.18e-05	0.000465	CcSEcCtD
Vidarabine—Asthenia—Felbamate—epilepsy syndrome	9.17e-05	0.000465	CcSEcCtD
Vidarabine—Vision blurred—Pregabalin—epilepsy syndrome	9.17e-05	0.000464	CcSEcCtD
Vidarabine—Chest pain—Valproic Acid—epilepsy syndrome	9.16e-05	0.000464	CcSEcCtD
Vidarabine—Anxiety—Valproic Acid—epilepsy syndrome	9.13e-05	0.000463	CcSEcCtD
Vidarabine—Tremor—Pregabalin—epilepsy syndrome	9.11e-05	0.000462	CcSEcCtD
Vidarabine—Rash—Midazolam—epilepsy syndrome	9.11e-05	0.000461	CcSEcCtD
Vidarabine—Dizziness—Fosphenytoin—epilepsy syndrome	9.1e-05	0.000461	CcSEcCtD
Vidarabine—Dermatitis—Midazolam—epilepsy syndrome	9.1e-05	0.000461	CcSEcCtD
Vidarabine—Urticaria—Carbamazepine—epilepsy syndrome	9.08e-05	0.00046	CcSEcCtD
Vidarabine—Vomiting—Levetiracetam—epilepsy syndrome	9.07e-05	0.000459	CcSEcCtD
Vidarabine—Discomfort—Valproic Acid—epilepsy syndrome	9.05e-05	0.000459	CcSEcCtD
Vidarabine—Headache—Midazolam—epilepsy syndrome	9.05e-05	0.000458	CcSEcCtD
Vidarabine—Cladribine—ABCG2—epilepsy syndrome	8.99e-05	0.0163	CrCbGaD
Vidarabine—Rash—Levetiracetam—epilepsy syndrome	8.99e-05	0.000456	CcSEcCtD
Vidarabine—Dermatitis—Levetiracetam—epilepsy syndrome	8.98e-05	0.000455	CcSEcCtD
Vidarabine—Asthenia—Zonisamide—epilepsy syndrome	8.98e-05	0.000455	CcSEcCtD
Vidarabine—Dry mouth—Valproic Acid—epilepsy syndrome	8.96e-05	0.000454	CcSEcCtD
Vidarabine—Agitation—Pregabalin—epilepsy syndrome	8.94e-05	0.000453	CcSEcCtD
Vidarabine—Headache—Levetiracetam—epilepsy syndrome	8.93e-05	0.000453	CcSEcCtD
Vidarabine—Angioedema—Pregabalin—epilepsy syndrome	8.89e-05	0.00045	CcSEcCtD
Vidarabine—Hypersensitivity—Clonazepam—epilepsy syndrome	8.88e-05	0.00045	CcSEcCtD
Vidarabine—Dizziness—Vigabatrin—epilepsy syndrome	8.87e-05	0.00045	CcSEcCtD
Vidarabine—Hypersensitivity—Phenytoin—epilepsy syndrome	8.83e-05	0.000447	CcSEcCtD
Vidarabine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	8.78e-05	0.000445	CcSEcCtD
Vidarabine—Urticaria—Lamotrigine—epilepsy syndrome	8.78e-05	0.000445	CcSEcCtD
Vidarabine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	8.78e-05	0.000445	CcSEcCtD
Vidarabine—Bradycardia—Topiramate—epilepsy syndrome	8.78e-05	0.000445	CcSEcCtD
Vidarabine—Nausea—Propofol—epilepsy syndrome	8.77e-05	0.000444	CcSEcCtD
Vidarabine—Tension—Gabapentin—epilepsy syndrome	8.75e-05	0.000443	CcSEcCtD
Vidarabine—Vomiting—Fosphenytoin—epilepsy syndrome	8.75e-05	0.000443	CcSEcCtD
Vidarabine—Dysgeusia—Gabapentin—epilepsy syndrome	8.73e-05	0.000443	CcSEcCtD
Vidarabine—Dizziness—Diazepam—epilepsy syndrome	8.73e-05	0.000443	CcSEcCtD
Vidarabine—Syncope—Pregabalin—epilepsy syndrome	8.72e-05	0.000442	CcSEcCtD
Vidarabine—Rash—Fosphenytoin—epilepsy syndrome	8.68e-05	0.00044	CcSEcCtD
Vidarabine—Dermatitis—Fosphenytoin—epilepsy syndrome	8.67e-05	0.000439	CcSEcCtD
Vidarabine—Nervousness—Gabapentin—epilepsy syndrome	8.66e-05	0.000439	CcSEcCtD
Vidarabine—Asthenia—Clonazepam—epilepsy syndrome	8.65e-05	0.000438	CcSEcCtD
Vidarabine—Adenosine triphosphate—ABCC2—epilepsy syndrome	8.65e-05	0.0157	CrCbGaD
Vidarabine—Back pain—Gabapentin—epilepsy syndrome	8.63e-05	0.000437	CcSEcCtD
Vidarabine—Headache—Fosphenytoin—epilepsy syndrome	8.62e-05	0.000437	CcSEcCtD
Vidarabine—Palpitations—Pregabalin—epilepsy syndrome	8.6e-05	0.000436	CcSEcCtD
Vidarabine—Asthenia—Phenytoin—epilepsy syndrome	8.59e-05	0.000435	CcSEcCtD
Vidarabine—Nausea—Midazolam—epilepsy syndrome	8.58e-05	0.000435	CcSEcCtD
Vidarabine—Hypoaesthesia—Topiramate—epilepsy syndrome	8.58e-05	0.000435	CcSEcCtD
Vidarabine—Tachycardia—Valproic Acid—epilepsy syndrome	8.57e-05	0.000434	CcSEcCtD
Vidarabine—Loss of consciousness—Pregabalin—epilepsy syndrome	8.55e-05	0.000433	CcSEcCtD
Vidarabine—Asthenia—Oxcarbazepine—epilepsy syndrome	8.55e-05	0.000433	CcSEcCtD
Vidarabine—Vomiting—Vigabatrin—epilepsy syndrome	8.53e-05	0.000432	CcSEcCtD
Vidarabine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	8.49e-05	0.00043	CcSEcCtD
Vidarabine—Cough—Pregabalin—epilepsy syndrome	8.49e-05	0.00043	CcSEcCtD
Vidarabine—Nausea—Levetiracetam—epilepsy syndrome	8.47e-05	0.000429	CcSEcCtD
Vidarabine—Rash—Vigabatrin—epilepsy syndrome	8.46e-05	0.000429	CcSEcCtD
Vidarabine—Dizziness—Felbamate—epilepsy syndrome	8.45e-05	0.000428	CcSEcCtD
Vidarabine—Dermatitis—Vigabatrin—epilepsy syndrome	8.45e-05	0.000428	CcSEcCtD
Vidarabine—Convulsion—Pregabalin—epilepsy syndrome	8.43e-05	0.000427	CcSEcCtD
Vidarabine—Hypersensitivity—Carbamazepine—epilepsy syndrome	8.42e-05	0.000427	CcSEcCtD
Vidarabine—Vision blurred—Gabapentin—epilepsy syndrome	8.41e-05	0.000426	CcSEcCtD
Vidarabine—Headache—Vigabatrin—epilepsy syndrome	8.4e-05	0.000426	CcSEcCtD
Vidarabine—Hypertension—Pregabalin—epilepsy syndrome	8.4e-05	0.000426	CcSEcCtD
Vidarabine—Vomiting—Diazepam—epilepsy syndrome	8.4e-05	0.000425	CcSEcCtD
Vidarabine—Tremor—Gabapentin—epilepsy syndrome	8.36e-05	0.000423	CcSEcCtD
Vidarabine—Rash—Diazepam—epilepsy syndrome	8.33e-05	0.000422	CcSEcCtD
Vidarabine—Dermatitis—Diazepam—epilepsy syndrome	8.32e-05	0.000422	CcSEcCtD
Vidarabine—Chest pain—Pregabalin—epilepsy syndrome	8.28e-05	0.00042	CcSEcCtD
Vidarabine—Dizziness—Zonisamide—epilepsy syndrome	8.27e-05	0.000419	CcSEcCtD
Vidarabine—Headache—Diazepam—epilepsy syndrome	8.27e-05	0.000419	CcSEcCtD
Vidarabine—Anxiety—Pregabalin—epilepsy syndrome	8.25e-05	0.000418	CcSEcCtD
Vidarabine—Hypotension—Valproic Acid—epilepsy syndrome	8.21e-05	0.000416	CcSEcCtD
Vidarabine—Asthenia—Carbamazepine—epilepsy syndrome	8.2e-05	0.000416	CcSEcCtD
Vidarabine—Agitation—Gabapentin—epilepsy syndrome	8.2e-05	0.000415	CcSEcCtD
Vidarabine—Discomfort—Pregabalin—epilepsy syndrome	8.18e-05	0.000415	CcSEcCtD
Vidarabine—Nausea—Fosphenytoin—epilepsy syndrome	8.18e-05	0.000414	CcSEcCtD
Vidarabine—Angioedema—Gabapentin—epilepsy syndrome	8.15e-05	0.000413	CcSEcCtD
Vidarabine—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.14e-05	0.000413	CcSEcCtD
Vidarabine—Vomiting—Felbamate—epilepsy syndrome	8.13e-05	0.000412	CcSEcCtD
Vidarabine—Dry mouth—Pregabalin—epilepsy syndrome	8.1e-05	0.00041	CcSEcCtD
Vidarabine—Rash—Felbamate—epilepsy syndrome	8.06e-05	0.000408	CcSEcCtD
Vidarabine—Dermatitis—Felbamate—epilepsy syndrome	8.05e-05	0.000408	CcSEcCtD
Vidarabine—Tinnitus—Topiramate—epilepsy syndrome	8.04e-05	0.000407	CcSEcCtD
Vidarabine—Headache—Felbamate—epilepsy syndrome	8.01e-05	0.000406	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8e-05	0.000405	CcSEcCtD
Vidarabine—Flushing—Topiramate—epilepsy syndrome	8e-05	0.000405	CcSEcCtD
Vidarabine—Cardiac disorder—Topiramate—epilepsy syndrome	8e-05	0.000405	CcSEcCtD
Vidarabine—Syncope—Gabapentin—epilepsy syndrome	8e-05	0.000405	CcSEcCtD
Vidarabine—Dizziness—Clonazepam—epilepsy syndrome	7.97e-05	0.000404	CcSEcCtD
Vidarabine—Nausea—Vigabatrin—epilepsy syndrome	7.97e-05	0.000404	CcSEcCtD
Vidarabine—Vomiting—Zonisamide—epilepsy syndrome	7.96e-05	0.000403	CcSEcCtD
Vidarabine—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.94e-05	0.000402	CcSEcCtD
Vidarabine—Asthenia—Lamotrigine—epilepsy syndrome	7.93e-05	0.000402	CcSEcCtD
Vidarabine—Dizziness—Phenytoin—epilepsy syndrome	7.92e-05	0.000401	CcSEcCtD
Vidarabine—Rash—Zonisamide—epilepsy syndrome	7.89e-05	0.0004	CcSEcCtD
Vidarabine—Paraesthesia—Valproic Acid—epilepsy syndrome	7.88e-05	0.0004	CcSEcCtD
Vidarabine—Palpitations—Gabapentin—epilepsy syndrome	7.88e-05	0.000399	CcSEcCtD
Vidarabine—Dermatitis—Zonisamide—epilepsy syndrome	7.88e-05	0.000399	CcSEcCtD
Vidarabine—Dizziness—Oxcarbazepine—epilepsy syndrome	7.88e-05	0.000399	CcSEcCtD
Vidarabine—Nausea—Diazepam—epilepsy syndrome	7.85e-05	0.000398	CcSEcCtD
Vidarabine—Loss of consciousness—Gabapentin—epilepsy syndrome	7.84e-05	0.000397	CcSEcCtD
Vidarabine—Headache—Zonisamide—epilepsy syndrome	7.84e-05	0.000397	CcSEcCtD
Vidarabine—Dyspnoea—Valproic Acid—epilepsy syndrome	7.83e-05	0.000397	CcSEcCtD
Vidarabine—Shock—Pregabalin—epilepsy syndrome	7.81e-05	0.000396	CcSEcCtD
Vidarabine—Somnolence—Valproic Acid—epilepsy syndrome	7.81e-05	0.000396	CcSEcCtD
Vidarabine—Cough—Gabapentin—epilepsy syndrome	7.78e-05	0.000394	CcSEcCtD
Vidarabine—Mediastinal disorder—Topiramate—epilepsy syndrome	7.77e-05	0.000394	CcSEcCtD
Vidarabine—Tachycardia—Pregabalin—epilepsy syndrome	7.75e-05	0.000393	CcSEcCtD
Vidarabine—Convulsion—Gabapentin—epilepsy syndrome	7.73e-05	0.000392	CcSEcCtD
Vidarabine—Hypertension—Gabapentin—epilepsy syndrome	7.7e-05	0.00039	CcSEcCtD
Vidarabine—Hyperhidrosis—Pregabalin—epilepsy syndrome	7.67e-05	0.000389	CcSEcCtD
Vidarabine—Vomiting—Clonazepam—epilepsy syndrome	7.67e-05	0.000389	CcSEcCtD
Vidarabine—Vomiting—Phenytoin—epilepsy syndrome	7.62e-05	0.000386	CcSEcCtD
Vidarabine—Rash—Clonazepam—epilepsy syndrome	7.6e-05	0.000385	CcSEcCtD
Vidarabine—Dermatitis—Clonazepam—epilepsy syndrome	7.6e-05	0.000385	CcSEcCtD
Vidarabine—Chest pain—Gabapentin—epilepsy syndrome	7.59e-05	0.000385	CcSEcCtD
Vidarabine—Nausea—Felbamate—epilepsy syndrome	7.59e-05	0.000385	CcSEcCtD
Vidarabine—Vomiting—Oxcarbazepine—epilepsy syndrome	7.58e-05	0.000384	CcSEcCtD
Vidarabine—Anxiety—Gabapentin—epilepsy syndrome	7.57e-05	0.000383	CcSEcCtD
Vidarabine—Dizziness—Carbamazepine—epilepsy syndrome	7.56e-05	0.000383	CcSEcCtD
Vidarabine—Headache—Clonazepam—epilepsy syndrome	7.55e-05	0.000383	CcSEcCtD
Vidarabine—Rash—Phenytoin—epilepsy syndrome	7.55e-05	0.000383	CcSEcCtD
Vidarabine—Dermatitis—Phenytoin—epilepsy syndrome	7.55e-05	0.000382	CcSEcCtD
Vidarabine—Rash—Oxcarbazepine—epilepsy syndrome	7.51e-05	0.000381	CcSEcCtD
Vidarabine—Pain—Valproic Acid—epilepsy syndrome	7.51e-05	0.00038	CcSEcCtD
Vidarabine—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.51e-05	0.00038	CcSEcCtD
Vidarabine—Headache—Phenytoin—epilepsy syndrome	7.5e-05	0.00038	CcSEcCtD
Vidarabine—Discomfort—Gabapentin—epilepsy syndrome	7.5e-05	0.00038	CcSEcCtD
Vidarabine—Headache—Oxcarbazepine—epilepsy syndrome	7.46e-05	0.000378	CcSEcCtD
Vidarabine—Nausea—Zonisamide—epilepsy syndrome	7.43e-05	0.000377	CcSEcCtD
Vidarabine—Dry mouth—Gabapentin—epilepsy syndrome	7.43e-05	0.000376	CcSEcCtD
Vidarabine—Hypotension—Pregabalin—epilepsy syndrome	7.42e-05	0.000376	CcSEcCtD
Vidarabine—Tension—Topiramate—epilepsy syndrome	7.36e-05	0.000373	CcSEcCtD
Vidarabine—Dysgeusia—Topiramate—epilepsy syndrome	7.35e-05	0.000372	CcSEcCtD
Vidarabine—Dizziness—Lamotrigine—epilepsy syndrome	7.31e-05	0.00037	CcSEcCtD
Vidarabine—Nervousness—Topiramate—epilepsy syndrome	7.29e-05	0.000369	CcSEcCtD
Vidarabine—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.28e-05	0.000369	CcSEcCtD
Vidarabine—Vomiting—Carbamazepine—epilepsy syndrome	7.27e-05	0.000368	CcSEcCtD
Vidarabine—Back pain—Topiramate—epilepsy syndrome	7.26e-05	0.000368	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.23e-05	0.000366	CcSEcCtD
Vidarabine—Rash—Carbamazepine—epilepsy syndrome	7.21e-05	0.000365	CcSEcCtD
Vidarabine—Dermatitis—Carbamazepine—epilepsy syndrome	7.2e-05	0.000365	CcSEcCtD
Vidarabine—Nausea—Clonazepam—epilepsy syndrome	7.16e-05	0.000363	CcSEcCtD
Vidarabine—Headache—Carbamazepine—epilepsy syndrome	7.16e-05	0.000363	CcSEcCtD
Vidarabine—Shock—Gabapentin—epilepsy syndrome	7.16e-05	0.000363	CcSEcCtD
Vidarabine—Paraesthesia—Pregabalin—epilepsy syndrome	7.13e-05	0.000361	CcSEcCtD
Vidarabine—Nausea—Phenytoin—epilepsy syndrome	7.12e-05	0.000361	CcSEcCtD
Vidarabine—Tachycardia—Gabapentin—epilepsy syndrome	7.1e-05	0.00036	CcSEcCtD
Vidarabine—Dyspnoea—Pregabalin—epilepsy syndrome	7.08e-05	0.000359	CcSEcCtD
Vidarabine—Nausea—Oxcarbazepine—epilepsy syndrome	7.08e-05	0.000359	CcSEcCtD
Vidarabine—Vision blurred—Topiramate—epilepsy syndrome	7.07e-05	0.000358	CcSEcCtD
Vidarabine—Somnolence—Pregabalin—epilepsy syndrome	7.06e-05	0.000358	CcSEcCtD
Vidarabine—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.04e-05	0.000357	CcSEcCtD
Vidarabine—Tremor—Topiramate—epilepsy syndrome	7.03e-05	0.000356	CcSEcCtD
Vidarabine—Vomiting—Lamotrigine—epilepsy syndrome	7.03e-05	0.000356	CcSEcCtD
Vidarabine—Urticaria—Valproic Acid—epilepsy syndrome	6.98e-05	0.000353	CcSEcCtD
Vidarabine—Rash—Lamotrigine—epilepsy syndrome	6.97e-05	0.000353	CcSEcCtD
Vidarabine—Dermatitis—Lamotrigine—epilepsy syndrome	6.96e-05	0.000353	CcSEcCtD
Vidarabine—Headache—Lamotrigine—epilepsy syndrome	6.92e-05	0.000351	CcSEcCtD
Vidarabine—Agitation—Topiramate—epilepsy syndrome	6.9e-05	0.000349	CcSEcCtD
Vidarabine—Hypotension—Gabapentin—epilepsy syndrome	6.8e-05	0.000345	CcSEcCtD
Vidarabine—Nausea—Carbamazepine—epilepsy syndrome	6.79e-05	0.000344	CcSEcCtD
Vidarabine—Pain—Pregabalin—epilepsy syndrome	6.79e-05	0.000344	CcSEcCtD
Vidarabine—Syncope—Topiramate—epilepsy syndrome	6.73e-05	0.000341	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.63e-05	0.000336	CcSEcCtD
Vidarabine—Palpitations—Topiramate—epilepsy syndrome	6.63e-05	0.000336	CcSEcCtD
Vidarabine—Loss of consciousness—Topiramate—epilepsy syndrome	6.6e-05	0.000334	CcSEcCtD
Vidarabine—Nausea—Lamotrigine—epilepsy syndrome	6.56e-05	0.000333	CcSEcCtD
Vidarabine—Cough—Topiramate—epilepsy syndrome	6.55e-05	0.000332	CcSEcCtD
Vidarabine—Paraesthesia—Gabapentin—epilepsy syndrome	6.54e-05	0.000331	CcSEcCtD
Vidarabine—Convulsion—Topiramate—epilepsy syndrome	6.5e-05	0.000329	CcSEcCtD
Vidarabine—Dyspnoea—Gabapentin—epilepsy syndrome	6.49e-05	0.000329	CcSEcCtD
Vidarabine—Hypertension—Topiramate—epilepsy syndrome	6.48e-05	0.000328	CcSEcCtD
Vidarabine—Somnolence—Gabapentin—epilepsy syndrome	6.47e-05	0.000328	CcSEcCtD
Vidarabine—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.47e-05	0.000328	CcSEcCtD
Vidarabine—Chest pain—Topiramate—epilepsy syndrome	6.39e-05	0.000324	CcSEcCtD
Vidarabine—Anxiety—Topiramate—epilepsy syndrome	6.37e-05	0.000323	CcSEcCtD
Vidarabine—Discomfort—Topiramate—epilepsy syndrome	6.31e-05	0.00032	CcSEcCtD
Vidarabine—Urticaria—Pregabalin—epilepsy syndrome	6.31e-05	0.00032	CcSEcCtD
Vidarabine—Asthenia—Valproic Acid—epilepsy syndrome	6.3e-05	0.000319	CcSEcCtD
Vidarabine—Dry mouth—Topiramate—epilepsy syndrome	6.25e-05	0.000317	CcSEcCtD
Vidarabine—Pain—Gabapentin—epilepsy syndrome	6.23e-05	0.000315	CcSEcCtD
Vidarabine—Shock—Topiramate—epilepsy syndrome	6.03e-05	0.000305	CcSEcCtD
Vidarabine—Tachycardia—Topiramate—epilepsy syndrome	5.98e-05	0.000303	CcSEcCtD
Vidarabine—Hyperhidrosis—Topiramate—epilepsy syndrome	5.92e-05	0.0003	CcSEcCtD
Vidarabine—Hypersensitivity—Pregabalin—epilepsy syndrome	5.85e-05	0.000296	CcSEcCtD
Vidarabine—Dizziness—Valproic Acid—epilepsy syndrome	5.81e-05	0.000294	CcSEcCtD
Vidarabine—Urticaria—Gabapentin—epilepsy syndrome	5.78e-05	0.000293	CcSEcCtD
Vidarabine—Hypotension—Topiramate—epilepsy syndrome	5.72e-05	0.00029	CcSEcCtD
Vidarabine—Asthenia—Pregabalin—epilepsy syndrome	5.7e-05	0.000289	CcSEcCtD
Vidarabine—Vomiting—Valproic Acid—epilepsy syndrome	5.58e-05	0.000283	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.58e-05	0.000283	CcSEcCtD
Vidarabine—Rash—Valproic Acid—epilepsy syndrome	5.54e-05	0.000281	CcSEcCtD
Vidarabine—Dermatitis—Valproic Acid—epilepsy syndrome	5.53e-05	0.00028	CcSEcCtD
Vidarabine—Headache—Valproic Acid—epilepsy syndrome	5.5e-05	0.000279	CcSEcCtD
Vidarabine—Paraesthesia—Topiramate—epilepsy syndrome	5.5e-05	0.000279	CcSEcCtD
Vidarabine—Dyspnoea—Topiramate—epilepsy syndrome	5.46e-05	0.000277	CcSEcCtD
Vidarabine—Somnolence—Topiramate—epilepsy syndrome	5.44e-05	0.000276	CcSEcCtD
Vidarabine—Hypersensitivity—Gabapentin—epilepsy syndrome	5.36e-05	0.000272	CcSEcCtD
Vidarabine—Dizziness—Pregabalin—epilepsy syndrome	5.25e-05	0.000266	CcSEcCtD
Vidarabine—Pain—Topiramate—epilepsy syndrome	5.24e-05	0.000265	CcSEcCtD
Vidarabine—Asthenia—Gabapentin—epilepsy syndrome	5.22e-05	0.000265	CcSEcCtD
Vidarabine—Nausea—Valproic Acid—epilepsy syndrome	5.22e-05	0.000264	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—SSTR3—epilepsy syndrome	5.2e-05	0.000559	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	5.15e-05	0.000553	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRDM4—epilepsy syndrome	5.13e-05	0.000551	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRICKLE1—epilepsy syndrome	5.13e-05	0.000551	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GRM8—epilepsy syndrome	5.11e-05	0.000549	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP2D6—epilepsy syndrome	5.09e-05	0.000546	CbGpPWpGaD
Vidarabine—Vomiting—Pregabalin—epilepsy syndrome	5.05e-05	0.000256	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—BDKRB2—epilepsy syndrome	5.01e-05	0.000538	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL12—epilepsy syndrome	5.01e-05	0.000538	CbGpPWpGaD
Vidarabine—Rash—Pregabalin—epilepsy syndrome	5.01e-05	0.000254	CcSEcCtD
Vidarabine—Dermatitis—Pregabalin—epilepsy syndrome	5e-05	0.000253	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—ARHGEF9—epilepsy syndrome	4.99e-05	0.000536	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—NPY2R—epilepsy syndrome	4.99e-05	0.000536	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR8—epilepsy syndrome	4.99e-05	0.000536	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR9—epilepsy syndrome	4.99e-05	0.000536	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—SSTR1—epilepsy syndrome	4.99e-05	0.000536	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NGF—epilepsy syndrome	4.98e-05	0.000535	CbGpPWpGaD
Vidarabine—Headache—Pregabalin—epilepsy syndrome	4.97e-05	0.000252	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CNR1—epilepsy syndrome	4.92e-05	0.000528	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GRM4—epilepsy syndrome	4.89e-05	0.000526	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GRM3—epilepsy syndrome	4.89e-05	0.000526	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—OPRD1—epilepsy syndrome	4.87e-05	0.000523	CbGpPWpGaD
Vidarabine—Urticaria—Topiramate—epilepsy syndrome	4.87e-05	0.000247	CcSEcCtD
Vidarabine—ADA—Metabolism—CHRM3—epilepsy syndrome	4.85e-05	0.000521	CbGpPWpGaD
Vidarabine—ADA—Metabolism—KCNJ11—epilepsy syndrome	4.85e-05	0.000521	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ADRA2A—epilepsy syndrome	4.84e-05	0.00052	CbGpPWpGaD
Vidarabine—ADK—Metabolism—BCHE—epilepsy syndrome	4.82e-05	0.000518	CbGpPWpGaD
Vidarabine—Dizziness—Gabapentin—epilepsy syndrome	4.81e-05	0.000244	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—SSTR2—epilepsy syndrome	4.8e-05	0.000516	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—HTR7—epilepsy syndrome	4.8e-05	0.000515	CbGpPWpGaD
Vidarabine—Nausea—Pregabalin—epilepsy syndrome	4.72e-05	0.000239	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—AGT—epilepsy syndrome	4.68e-05	0.000503	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CHRM1—epilepsy syndrome	4.67e-05	0.000502	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PDYN—epilepsy syndrome	4.67e-05	0.000502	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GRM1—epilepsy syndrome	4.67e-05	0.000502	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR7—epilepsy syndrome	4.67e-05	0.000502	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GRM8—epilepsy syndrome	4.64e-05	0.000498	CbGpPWpGaD
Vidarabine—Vomiting—Gabapentin—epilepsy syndrome	4.63e-05	0.000235	CcSEcCtD
Vidarabine—ADK—Metabolism—SLC2A1—epilepsy syndrome	4.6e-05	0.000494	CbGpPWpGaD
Vidarabine—Rash—Gabapentin—epilepsy syndrome	4.59e-05	0.000233	CcSEcCtD
Vidarabine—Dermatitis—Gabapentin—epilepsy syndrome	4.59e-05	0.000232	CcSEcCtD
Vidarabine—Headache—Gabapentin—epilepsy syndrome	4.56e-05	0.000231	CcSEcCtD
Vidarabine—ADK—Metabolism—PLCB1—epilepsy syndrome	4.55e-05	0.000489	CbGpPWpGaD
Vidarabine—ADK—Metabolism—TH—epilepsy syndrome	4.53e-05	0.000487	CbGpPWpGaD
Vidarabine—Hypersensitivity—Topiramate—epilepsy syndrome	4.51e-05	0.000229	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	4.51e-05	0.000484	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—TSC2—epilepsy syndrome	4.5e-05	0.000484	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ACKR4—epilepsy syndrome	4.49e-05	0.000482	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNAO1—epilepsy syndrome	4.42e-05	0.000475	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—OPRD1—epilepsy syndrome	4.42e-05	0.000475	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	4.41e-05	0.000474	CbGpPWpGaD
Vidarabine—Asthenia—Topiramate—epilepsy syndrome	4.39e-05	0.000223	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—GAL—epilepsy syndrome	4.39e-05	0.000472	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGF2—epilepsy syndrome	4.35e-05	0.000468	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CHRM3—epilepsy syndrome	4.34e-05	0.000467	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GRM5—epilepsy syndrome	4.34e-05	0.000467	CbGpPWpGaD
Vidarabine—Nausea—Gabapentin—epilepsy syndrome	4.32e-05	0.000219	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CHRM1—epilepsy syndrome	4.24e-05	0.000456	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GRM1—epilepsy syndrome	4.24e-05	0.000456	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PDYN—epilepsy syndrome	4.24e-05	0.000456	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR7—epilepsy syndrome	4.24e-05	0.000456	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	4.19e-05	0.00045	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6ST—epilepsy syndrome	4.14e-05	0.000445	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CHRM2—epilepsy syndrome	4.08e-05	0.000439	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—BDKRB1—epilepsy syndrome	4.08e-05	0.000439	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SSTR5—epilepsy syndrome	4.06e-05	0.000436	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SSTR4—epilepsy syndrome	4.06e-05	0.000436	CbGpPWpGaD
Vidarabine—Dizziness—Topiramate—epilepsy syndrome	4.05e-05	0.000205	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—AVP—epilepsy syndrome	4.04e-05	0.000434	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GAL—epilepsy syndrome	3.99e-05	0.000429	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GABBR1—epilepsy syndrome	3.97e-05	0.000427	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MTOR—epilepsy syndrome	3.96e-05	0.000426	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ABCG2—epilepsy syndrome	3.95e-05	0.000425	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GRM5—epilepsy syndrome	3.94e-05	0.000424	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CHRM3—epilepsy syndrome	3.94e-05	0.000424	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—POMC—epilepsy syndrome	3.94e-05	0.000423	CbGpPWpGaD
Vidarabine—Vomiting—Topiramate—epilepsy syndrome	3.89e-05	0.000197	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—CCR10—epilepsy syndrome	3.89e-05	0.000418	CbGpPWpGaD
Vidarabine—Rash—Topiramate—epilepsy syndrome	3.86e-05	0.000196	CcSEcCtD
Vidarabine—Dermatitis—Topiramate—epilepsy syndrome	3.86e-05	0.000195	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—CCL2—epilepsy syndrome	3.86e-05	0.000414	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP2C19—epilepsy syndrome	3.85e-05	0.000414	CbGpPWpGaD
Vidarabine—Headache—Topiramate—epilepsy syndrome	3.84e-05	0.000194	CcSEcCtD
Vidarabine—ADA—Metabolism—CYP11A1—epilepsy syndrome	3.83e-05	0.000411	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HRH3—epilepsy syndrome	3.81e-05	0.000409	CbGpPWpGaD
Vidarabine—ADK—Metabolism—HMOX1—epilepsy syndrome	3.78e-05	0.000406	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CX3CR1—epilepsy syndrome	3.78e-05	0.000406	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—OPRM1—epilepsy syndrome	3.75e-05	0.000403	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CAT—epilepsy syndrome	3.73e-05	0.000401	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CHRM2—epilepsy syndrome	3.71e-05	0.000398	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—BDKRB1—epilepsy syndrome	3.71e-05	0.000398	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CX3CL1—epilepsy syndrome	3.71e-05	0.000398	CbGpPWpGaD
Vidarabine—Nausea—Topiramate—epilepsy syndrome	3.64e-05	0.000184	CcSEcCtD
Vidarabine—ADK—Metabolism—ABCB1—epilepsy syndrome	3.63e-05	0.00039	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—JUN—epilepsy syndrome	3.61e-05	0.000388	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GABBR1—epilepsy syndrome	3.61e-05	0.000388	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR3—epilepsy syndrome	3.54e-05	0.00038	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	3.52e-05	0.000378	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HRH3—epilepsy syndrome	3.46e-05	0.000372	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP2D6—epilepsy syndrome	3.46e-05	0.000371	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—NPY—epilepsy syndrome	3.45e-05	0.000371	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	3.45e-05	0.00037	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCR5—epilepsy syndrome	3.43e-05	0.000369	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—OPRM1—epilepsy syndrome	3.4e-05	0.000366	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GRM2—epilepsy syndrome	3.4e-05	0.000365	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GPX1—epilepsy syndrome	3.38e-05	0.000363	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—HTR2A—epilepsy syndrome	3.36e-05	0.000361	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—FGF2—epilepsy syndrome	3.35e-05	0.00036	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CRH—epilepsy syndrome	3.33e-05	0.000358	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—OXT—epilepsy syndrome	3.33e-05	0.000358	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL2—epilepsy syndrome	3.33e-05	0.000358	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ADRA2A—epilepsy syndrome	3.29e-05	0.000354	CbGpPWpGaD
Vidarabine—ADA—Metabolism—BCHE—epilepsy syndrome	3.28e-05	0.000352	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR3—epilepsy syndrome	3.21e-05	0.000345	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—AGT—epilepsy syndrome	3.19e-05	0.000342	CbGpPWpGaD
Vidarabine—Adenosine triphosphate—ABCB1—epilepsy syndrome	3.18e-05	0.00578	CrCbGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—SRC—epilepsy syndrome	3.18e-05	0.000341	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—NPY—epilepsy syndrome	3.13e-05	0.000337	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SLC2A1—epilepsy syndrome	3.13e-05	0.000336	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—RELA—epilepsy syndrome	3.11e-05	0.000334	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PLCB1—epilepsy syndrome	3.09e-05	0.000332	CbGpPWpGaD
Vidarabine—ADA—Metabolism—TH—epilepsy syndrome	3.08e-05	0.000331	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SSTR3—epilepsy syndrome	3.07e-05	0.00033	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MTOR—epilepsy syndrome	3.05e-05	0.000327	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL3—epilepsy syndrome	3.02e-05	0.000325	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL2—epilepsy syndrome	3.02e-05	0.000325	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CRH—epilepsy syndrome	3.02e-05	0.000325	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—OXT—epilepsy syndrome	3.02e-05	0.000325	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR2—epilepsy syndrome	3.01e-05	0.000323	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—SST—epilepsy syndrome	3.01e-05	0.000323	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.01e-05	0.000323	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AGT—epilepsy syndrome	2.96e-05	0.000318	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SSTR1—epilepsy syndrome	2.95e-05	0.000317	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR8—epilepsy syndrome	2.95e-05	0.000317	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPY2R—epilepsy syndrome	2.95e-05	0.000317	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR9—epilepsy syndrome	2.95e-05	0.000317	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ARHGEF9—epilepsy syndrome	2.95e-05	0.000317	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRA2A—epilepsy syndrome	2.95e-05	0.000316	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOE—epilepsy syndrome	2.9e-05	0.000312	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GRM4—epilepsy syndrome	2.89e-05	0.000311	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GRM3—epilepsy syndrome	2.89e-05	0.000311	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DUSP4—epilepsy syndrome	2.84e-05	0.000305	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SSTR2—epilepsy syndrome	2.84e-05	0.000305	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL12—epilepsy syndrome	2.83e-05	0.000304	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—BDKRB2—epilepsy syndrome	2.83e-05	0.000304	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CASP3—epilepsy syndrome	2.8e-05	0.000301	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CNR1—epilepsy syndrome	2.78e-05	0.000298	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PLCB1—epilepsy syndrome	2.77e-05	0.000297	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GRM8—epilepsy syndrome	2.74e-05	0.000294	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PGF—epilepsy syndrome	2.74e-05	0.000294	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR2—epilepsy syndrome	2.73e-05	0.000294	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—SST—epilepsy syndrome	2.73e-05	0.000294	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR7—epilepsy syndrome	2.71e-05	0.000291	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—POMC—epilepsy syndrome	2.68e-05	0.000288	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.68e-05	0.000287	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCL2—epilepsy syndrome	2.62e-05	0.000282	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNAO1—epilepsy syndrome	2.61e-05	0.000281	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—OPRD1—epilepsy syndrome	2.61e-05	0.000281	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT3—epilepsy syndrome	2.58e-05	0.000277	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HMOX1—epilepsy syndrome	2.57e-05	0.000276	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL12—epilepsy syndrome	2.57e-05	0.000276	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.57e-05	0.000276	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CAT—epilepsy syndrome	2.54e-05	0.000273	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CNR1—epilepsy syndrome	2.52e-05	0.000271	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PLCB1—epilepsy syndrome	2.51e-05	0.00027	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CHRM1—epilepsy syndrome	2.51e-05	0.000269	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR7—epilepsy syndrome	2.51e-05	0.000269	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GRM1—epilepsy syndrome	2.51e-05	0.000269	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDYN—epilepsy syndrome	2.51e-05	0.000269	CbGpPWpGaD
Vidarabine—ADK—Metabolism—POMC—epilepsy syndrome	2.49e-05	0.000268	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ABCB1—epilepsy syndrome	2.47e-05	0.000265	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR7—epilepsy syndrome	2.46e-05	0.000264	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—SRC—epilepsy syndrome	2.44e-05	0.000262	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HBEGF—epilepsy syndrome	2.39e-05	0.000257	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CDC42—epilepsy syndrome	2.36e-05	0.000253	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GAL—epilepsy syndrome	2.36e-05	0.000253	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GFAP—epilepsy syndrome	2.36e-05	0.000253	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT3—epilepsy syndrome	2.35e-05	0.000252	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GRM5—epilepsy syndrome	2.33e-05	0.00025	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CHRM3—epilepsy syndrome	2.33e-05	0.00025	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CASP2—epilepsy syndrome	2.33e-05	0.00025	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GPX1—epilepsy syndrome	2.29e-05	0.000247	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AVP—epilepsy syndrome	2.28e-05	0.000245	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ALB—epilepsy syndrome	2.27e-05	0.000244	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CX3CR1—epilepsy syndrome	2.23e-05	0.00024	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CHRM2—epilepsy syndrome	2.19e-05	0.000235	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BDKRB1—epilepsy syndrome	2.19e-05	0.000235	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CX3CL1—epilepsy syndrome	2.19e-05	0.000235	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CDC42—epilepsy syndrome	2.14e-05	0.00023	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GABBR1—epilepsy syndrome	2.13e-05	0.000229	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AVP—epilepsy syndrome	2.07e-05	0.000223	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HRH3—epilepsy syndrome	2.04e-05	0.000219	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AGT—epilepsy syndrome	2.01e-05	0.000216	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—OPRM1—epilepsy syndrome	2.01e-05	0.000216	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—epilepsy syndrome	1.99e-05	0.000213	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—epilepsy syndrome	1.97e-05	0.000212	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOE—epilepsy syndrome	1.97e-05	0.000212	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.94e-05	0.000208	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR3—epilepsy syndrome	1.9e-05	0.000204	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.9e-05	0.000204	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPY—epilepsy syndrome	1.85e-05	0.000199	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.85e-05	0.000199	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AGT—epilepsy syndrome	1.8e-05	0.000194	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL2—epilepsy syndrome	1.79e-05	0.000192	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HSPB1—epilepsy syndrome	1.79e-05	0.000192	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CRH—epilepsy syndrome	1.79e-05	0.000192	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—OXT—epilepsy syndrome	1.79e-05	0.000192	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL3—epilepsy syndrome	1.79e-05	0.000192	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR5—epilepsy syndrome	1.76e-05	0.000189	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.72e-05	0.000185	CbGpPWpGaD
Vidarabine—ADA—Metabolism—POMC—epilepsy syndrome	1.69e-05	0.000182	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.66e-05	0.000179	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTK2B—epilepsy syndrome	1.66e-05	0.000178	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TSC1—epilepsy syndrome	1.66e-05	0.000178	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AGT—epilepsy syndrome	1.64e-05	0.000176	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SST—epilepsy syndrome	1.61e-05	0.000173	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR2—epilepsy syndrome	1.61e-05	0.000173	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NTRK2—epilepsy syndrome	1.61e-05	0.000173	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DUSP6—epilepsy syndrome	1.6e-05	0.000172	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRA2A—epilepsy syndrome	1.58e-05	0.00017	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLAT—epilepsy syndrome	1.57e-05	0.000169	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALB—epilepsy syndrome	1.54e-05	0.000166	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL12—epilepsy syndrome	1.52e-05	0.000163	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.52e-05	0.000163	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—AKT1—epilepsy syndrome	1.52e-05	0.000163	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—POMC—epilepsy syndrome	1.52e-05	0.000163	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.51e-05	0.000162	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.51e-05	0.000162	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—JUNB—epilepsy syndrome	1.49e-05	0.00016	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CNR1—epilepsy syndrome	1.49e-05	0.00016	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLCB1—epilepsy syndrome	1.48e-05	0.00016	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR7—epilepsy syndrome	1.45e-05	0.000156	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HBEGF—epilepsy syndrome	1.41e-05	0.000152	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT3—epilepsy syndrome	1.39e-05	0.000149	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—POMC—epilepsy syndrome	1.38e-05	0.000148	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADAM10—epilepsy syndrome	1.35e-05	0.000145	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—epilepsy syndrome	1.35e-05	0.000145	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL2—epilepsy syndrome	1.35e-05	0.000145	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—S100B—epilepsy syndrome	1.28e-05	0.000137	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SOCS3—epilepsy syndrome	1.27e-05	0.000136	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDC42—epilepsy syndrome	1.26e-05	0.000136	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AVP—epilepsy syndrome	1.22e-05	0.000131	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HES1—epilepsy syndrome	1.16e-05	0.000124	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FYN—epilepsy syndrome	1.13e-05	0.000121	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.12e-05	0.00012	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.12e-05	0.00012	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.08e-05	0.000116	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NGF—epilepsy syndrome	1.07e-05	0.000115	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR5—epilepsy syndrome	1.04e-05	0.000112	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.02e-05	0.000109	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AKT1—epilepsy syndrome	9.99e-06	0.000107	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TSC2—epilepsy syndrome	9.67e-06	0.000104	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AGT—epilepsy syndrome	9.66e-06	0.000104	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOE—epilepsy syndrome	9.47e-06	0.000102	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KDR—epilepsy syndrome	9.27e-06	9.96e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCB—epilepsy syndrome	8.93e-06	9.59e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6ST—epilepsy syndrome	8.89e-06	9.55e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—POMC—epilepsy syndrome	8.13e-06	8.74e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL2—epilepsy syndrome	7.96e-06	8.55e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGF2—epilepsy syndrome	7.19e-06	7.73e-05	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AKT1—epilepsy syndrome	6.79e-06	7.29e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RELA—epilepsy syndrome	6.68e-06	7.17e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MTOR—epilepsy syndrome	6.55e-06	7.03e-05	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.08e-06	6.53e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CASP3—epilepsy syndrome	6.02e-06	6.47e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—JUN—epilepsy syndrome	5.85e-06	6.28e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP9—epilepsy syndrome	5.69e-06	6.11e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT1—epilepsy syndrome	5.52e-06	5.93e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SRC—epilepsy syndrome	5.25e-06	5.64e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFA—epilepsy syndrome	5.11e-06	5.49e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT1—epilepsy syndrome	3.26e-06	3.5e-05	CbGpPWpGaD
